Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 331 followers
Latest posts
Last updated about 11 hours ago
Novartis winds down ph. 1 solid tumor program due to lack of efficacy
about 11 hours ago
Novartis has jettisoned an anti-cancer protein from its pipeline after the molecule...
Assessing Myelin Formation and Therapeutic Response Using 3D Organoids
about 11 hours ago
Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a...
White House frustration may have fueled FDA’s Moderna walk back: Politico
about 14 hours ago
Politico has reported that the White House isn’t happy with the FDA’s...
J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer’s therapy
about 16 hours ago
Johnson & Johnson has paused further enrollment in a phase 2b trial...
Study finds blood test can predict age of Alzheimer's onset
about 19 hours ago
Newly FDA-cleared blood tests are now making it easier for doctors to...
Sanofi backs Altesa's $75M series B to bankroll antiviral’s mid-stage rhinovirus study
about 19 hours ago
Sanofi has backed the $75 million series B of a rhinovirus-focused biotech...
NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports
1 day ago
Following the departure of Jim O'Neill, National Institutes of Health Director Jay...
GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
1 day ago
Pharma giant GSK is launching a five-year collaboration with Jackson Laboratory–New York...
Blood from pediatricians yields potential new medicines for respiratory viruses
1 day ago
Constant exposure to diverse diseases is an occupational hazard for all healthcare...
Senate HELP Committee chair pitches proposals for FDA reform
1 day ago
In his report, Senator Bill Cassidy suggested a slate of changes to...
Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
1 day ago
In a deal with Theriva Biologics potentially worth as much as $36...
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
1 day ago
Only a couple of months ago, Sensei Biotherapeutics was laying off staff...